: Keylime Kush by Lotus Cannabis Co.
This milestone is a long-time coming for our team of Okanagan legacy growers led by Carl Correia and Jason Brown and is another catalyst in the Lotus sales evolution this year. Lotus has also applied for three additional provincial product calls and continues to utilize the business-to-business wholesale market when favourable. Lotus’ Keylime Kush is now listed in British Columbia, with the Black Blossom listed in British Columbia, Alberta, and Manitoba with Pistol and Paris, and with the Kalifornia and Tranquil Elephantizer listed in Ontario.
For more information on the Keylime Kush and our other Lotus-grown cultivars, please visit lotuscannabis.ca/flower
ON BEHALF OF LOTUS VENTURES INC:
Lotus Ventures Inc.
Dale McClanaghan, President and CEO
About Lotus Ventures Inc.
Lotus Ventures Inc. is a BC-based licensed producer of premium cannabis. Lotus owns the premium-craft consumer brand Lotus Cannabis Co. which has had its cannabis flower sold by wholesale partners in all provinces to date. Lotus is an experienced cultivator on a mission to produce the cleanest and most consistent premium cannabis in Canada. With operations in the North Okanagan B.C., the Lotus Cannabis team has launched popular cultivars like the Keylime Kush, Black Blossom, Tranquil Elephantizer and Kalifornia and currently has flower being sold in British Columbia, Alberta, Manitoba, and Ontario.
To invest in the Company, Lotus Ventures Inc. is listed on the Canadian Securities Exchange (CSE:J), on the OTC Markets (OTC:LTTSF) and on the Frankfurt Stock Exchange (FRA:LV9).
For More Information:
President & CEO
(604) – 644 – 9844
Investor Relations & Communications
(604) – 842 – 4625
(604) – 842 – 4625
To learn more, visit lotuscannabis.ca and follow the Lotus Cannabis Co. brand on social media.
This document includes certain statements that are not descriptions of historical facts but are forward-looking statements. Such statements include, among others, those concerning our expected financial performance and strategic and operational plans, our future operating results, our expectations regarding the market for medical and recreational cannabis products, our expectations regarding the continued growth of the medical and recreational cannabis market, as well as all assumptions, expectations, predictions, intentions, or beliefs about future events. Users are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause our actual results to differ materially from those anticipated, expressed or implied in the forward-looking statements. These risks and uncertainties have not been documented or mentioned in this document nor other communications made by the company. The words “believe,” “expect,” “anticipate,” “project,” “targets,” “optimistic,” “intend,” “aim,” “will” or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.